Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroendocrine neoplasm that involves the duodenum.
Biomarker and diagnostic research for duodenal neuroendocrine neoplasm has been reported in the published literature.
No clinical trials have been registered for duodenal neuroendocrine neoplasm.
145 publications have been identified in PubMed for duodenal neuroendocrine neoplasm. Research spans Case Report / Case Series (35%), Epidemiology / Natural History (17%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 51 | 35% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Disease patterns and progression
24 |
17% |
Clinical study results | 21 | 14% |
Research summaries | 18 | 12% |
Laboratory research | 17 | 12% |
Testing and diagnosis research | 13 | 9% |
Other research | 1 | 1% |
Lee Y (2026). [PMID: 41251953](https://pubmed.ncbi.nlm.nih.gov/41251953/). *Dig Endosc*. [Epidemiology / Natural History]
Mete O (2026). [PMID: 41537937](https://pubmed.ncbi.nlm.nih.gov/41537937/). *Endocr Pathol*. [Diagnostic / Biomarker]
Caringi S (2026). [PMID: 42192910](https://pubmed.ncbi.nlm.nih.gov/42192910/). *Cancers (Basel)*. [Review / Meta-Analysis]
Kawakubo N (2026). [PMID: 41213650](https://pubmed.ncbi.nlm.nih.gov/41213650/). *J Adolesc Young Adult Oncol*. [Epidemiology / Natural History]
Alfouzan M (2026). [PMID: 41837089](https://pubmed.ncbi.nlm.nih.gov/41837089/). *Int J Surg Case Rep*. [Case Report / Case Series]
Krishnan SK (2026). [PMID: 42147504](https://pubmed.ncbi.nlm.nih.gov/42147504/). *Cureus*. [Epidemiology / Natural History]
Synn SB (2026). [PMID: 41846450](https://pubmed.ncbi.nlm.nih.gov/41846450/). *Korean J Helicobacter Up Gastrointest Res*. [Case Report / Case Series]
Nappo G (2026). [PMID: 42154175](https://pubmed.ncbi.nlm.nih.gov/42154175/). *Updates Surg*. [Clinical Trial Publication]
Carreño A (2026). [PMID: 42007667](https://pubmed.ncbi.nlm.nih.gov/42007667/). *Birth Defects Res*. [Epidemiology / Natural History]
Beger HG (2026). [PMID: 41651957](https://pubmed.ncbi.nlm.nih.gov/41651957/). *Surg Endosc*. [Review / Meta-Analysis]
AI-curated news mentioning duodenal neuroendocrine neoplasm
Updated Feb 28, 2026
A recent study identifies positive margins and lymphovascular invasion as significant risk factors for remnant tumors or late recurrence in patients undergoing endoscopic or local resection of duodenal neuroendocrine tumors. These findings could inform surgical approaches and post-operative monitoring strategies.